Found 924 results
Jia P, Zhao Z, Hulgan T, Bush WS, Samuels DC, Bloss C, Heaton RK, Ellis RJ, Schork N, Marra CM, et al. Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group study. Am J Med Genet B Neuropsychiatr Genet. 2017 ;174(4):413-426.
Becker AB, Qian J, Gelman B, Yang M, Bauer P, Koeppen AH. Heart and Nervous System Pathology in Compound Heterozygous Friedreich Ataxia.; 2017.
Clark US, Sweet LH, Morgello S, Philip NS, Cohen R. High early life stress and aberrant amygdala activity: risk factors for elevated neuropsychiatric symptoms in HIV+ adults. Brain Imaging Behav. 2017 ;11(3):649-665.
Roth W, Morgello S, Goldman JE, Mohr JP, Elkind MSV, Marshall RS, Gutierrez J. Histopathological Differences Between the Anterior and Posterior Brain Arteries as a Function of Aging. Stroke. 2017 ;48(3):638-644.
Roth W, Morgello S, Goldman JE, Mohr JP, Elkind MSV, Marshall RS, Gutierrez J. Histopathological Differences Between the Anterior and Posterior Brain Arteries as a Function of Aging.; 2017 p. STROKEAHA.116.015630.
Keltner JR, Connolly CG, Vaida F, Jenkinson M, Fennema-Notestine C, Archibald SL, Akkari C, Schlein A, Lee J, Wang D, et al. HIV Distal Neuropathic Pain Is Associated with Smaller Ventral Posterior Cingulate Cortex. Pain Med. 2017 ;18(3):428-440.
Nitkiewicz J, Borjabad A, Morgello S, Murray J, Chao W, Emdad L, Fisher P, Potash MJ, Volsky DJ. HIV induces expression of complement component C3 in astrocytes by NF-ΚB-dependent activation of interleukin-6 synthesis.; 2017.
Prevedel L, Morocho C, Bennett MV, Eugenin EA. HIV-Associated Cardiovascular Disease: Role of Connexin 43. Am J Pathol. 2017 ;187(9):1960-1970.
Castellano P, Prevedel L, Eugenin EA. HIV-infected macrophages and microglia that survive acute infection become viral reservoirs by a mechanism involving Bim. Scientific Reports. 2017 ;7(1).
Douville RN, Nath A. Human Endogenous Retrovirus-K and TDP-43 Expression Bridges ALS and HIV Neuropathology. [Internet]. 2017 ;8:1986. Available from:
Gonzalez-Perez M, Peters PJ, O'Connell O, Silva N, Harbison C, Macri SCummings, Kaliyaperumal S, Luzuriaga K, Clapham PR. Identification of Emerging Macrophage-Tropic HIV-1 R5 Variants in Brain Tissue of AIDS Patients without Severe Neurological Complications. J Virol. 2017 ;91(20).
Mahajan SD, Aalinkeel R, Parikh NU, Jacob A, Cwiklinski K, Sandhu P, Le K, Loftus AW, Schwartz SA, Quigg RJ, et al. Immunomodulatory Role of Complement Proteins in the Neuropathology Associated with Opiate Abuse and HIV-1 Co-Morbidity. Immunological InvestigationsImmunological Investigations [Internet]. 2017 ;46(8):816 - 832. Available from:
Kuhn T, Sayegh P, Jones JD, Smith J, Sarma MK, Ragin A, Singer EJ, M Thomas A, Thames AD, Castellon SA, et al. Improvements in brain and behavior following eradication of hepatitis C. J Neurovirol. 2017 ;23(4):593-602.
Yang J, Ngan DA, Tam S, Leung J, Sin DD, Man SP. Increased bacterial load in the small intestine but not lungs of HIV subjects. 2017 .
Christensen B, Qin Z, Byrd D, Yu F, Morgello S, Gelman B, Moore D, Grant I, Singer EJ, Fox HS, et al. Measures of Physical and Mental Independence Among HIV-Positive Individuals: Impact of Substance Use Disorder. AIDS Res Hum Retroviruses. 2017 ;33(10):1048-1055.
Xu Z, Asahchop EL, Branton WG, Gelman B, Power C, Hobman TC. MicroRNAs upregulated during HIV infection target peroxisome biogenesis factors: Implications for virus biology, disease mechanisms and neuropathology. PLoS Pathog. 2017 ;13(6):e1006360.
Wyczechowska D, Lin H-Y, LaPlante A, Jeansonne D, Lassak A, Parsons CH, Molina PE, Peruzzi F. A miRNA Signature for Cognitive Deficits and Alcohol Use Disorder in Persons Living with HIV/AIDS. [Internet]. 2017 ;10:385. Available from:
Xing Y, Shepherd N, Lan J, Li W, Rane S, Gupta SK, Zhang S, Dong J, Yu Q. MMPs/TIMPs imbalances in the peripheral blood and cerebrospinal fluid are associated with the pathogenesis of HIV-1-associated neurocognitive disorders. Brain Behav Immun [Internet]. 2017 . Available from:
Roda WC, Li MY, Akinwumi MS, Asahchop EL, Gelman B, Witwer KW, Power C. Modeling brain lentiviral infections during antiretroviral therapy in AIDS. J Neurovirol. 2017 ;23(4):577-586.
Ubaida-Mohien C, Lamberty B, Dickens AM, Mielke MM, Marcotte TD, Sacktor N, Grant I, Letendre S, Franklin D, Cibrowski P, et al. Modifications in acute phase and complement systems predict shifts in cognitive status of HIV-infected patients. AIDS. 2017 ;31(10):1365-1378.
Shapshak P, Levine AJ, Foley BT, Somboonwit C, Singer EJ, Chiappelli F, Sinnott JT, Soontornniyomkij V. Neuropathology of HIV-1 disease. In: Global Virology II - HIV and NeuroAIDS. 1st ed. Global Virology II - HIV and NeuroAIDS. Springer; 2017. pp. 143-208.
Sanfilippo C, Pinzone MR, Cambria D, Longo A, Palumbo M, Di Marco R, Condorelli F, Nunnari G, Malaguarnera L, Di Rosa M. OAS Gene Family Expression Is Associated with HIV-Related Neurocognitive Disorders. Mol Neurobiol. 2017 .
Singer EJ, Nemanim N. The Persistence of HIV-Associated Neurocognitive Disorder (HAND) in the Era of Combined Antiretroviral Therapy (cART). In: Global Virology II - HIV and NeuroAIDS. Global Virology II - HIV and NeuroAIDS. Springer; 2017. pp. 375-403.
Yuen T, Brouillette M-J, Fellows LK, Ellis RJ, Letendre S, Heaton RK, Mayo N. Personalized Risk Index for Neurocognitive Decline Among People With Well-Controlled HIV Infection. J Acquir Immune Defic Syndr. 2017 ;76(1):48-54.
Bryant AK, Moore D, Burdo TH, Lakritz JR, Gouaux B, Soontornniyomkij V, Achim C, Masliah E, Grant I, Levine AJ, et al. Plasma soluble CD163 is associated with postmortem brain pathology in human immunodeficiency virus infection. AIDS. 2017 ;31(7):973-979.